Counterfeits: Opportunities for MEDICRIME, Challenges for IMPACT
This article was originally published in RAJ Devices
Alan Chalmers reports that progress was made at a conference on the Council of Europe's proposed MEDICRIME convention, despite the controversy surrounding the World Health Organization's IMPACT initiative.
You may also be interested in...
Alan Chalmers reports from the Swiss agency’s International Regulatory Symposium.
New Swiss requirements on submissions for generics and products with known APIs get industry thumbs up
Recently implemented Swiss rules relating to marketing submissions for generics and products with known active pharmaceutical ingredients make the application process clearer and enable regulatory timeframes to be maintained.
International Conference on Harmonisation technical working groups will now be expanded to allow active participation by experts from qualifying members of the Global Cooperation Group1. This was a key development of the ICH steering committee's meeting in Fukuoka, Japan, which took place from 6-11 November and marked the 20th anniversary of the ICH.